Suppr超能文献

无风团的特发性组胺能性血管性水肿:31例病例系列

Idiopathic histaminergic angioedema without wheals: a case series of 31 patients.

作者信息

Faisant C, Boccon-Gibod I, Mansard C, Dumestre Perard C, Pralong P, Chatain C, Deroux A, Bouillet L

机构信息

Department of Internal Medicine, Grenoble University Hospital.

Grenoble Alps University.

出版信息

Clin Exp Immunol. 2016 Jul;185(1):81-5. doi: 10.1111/cei.12789. Epub 2016 Apr 13.

Abstract

Idiopathic histaminergic acquired angioedema (IH-AAE) is a common cause of recurrent angioedema without wheals. It is a mast cell-mediated disease thought to belong to the same clinical entity as chronic urticaria (CU). The objective of this study was to describe the clinical and epidemiological characteristics of IH-AAE patients. From 2014 to 2015, 534 patients were seen at our national reference centre for angioedema and/or urticaria. Among them, we identified 31 patients with idiopathic histaminergic acquired angioedema without wheals (IH-AAE). Thirty-one patients (15 men and 16 women) with a mean age of 50 years met the criteria for IH-AAE. The average delay in diagnosis was 6·3 years. A history of allergy was found in 12 patients (38·7%), nine suffering from allergic rhinitis. The mean duration of attacks was 28·1 h. The AE attack was located in the upper respiratory tract in 54·8% of cases (17 patients). A lingual location was found in 29% of patients. Men were more likely than women to have an upper airway involvement. No intubations or admissions to intensive care units were reported. The dosage of anti-histamines to control the symptoms was onefold the recommended dose in 51·6% of patients (16 patients), twofold in 32% (10 patients) and three-fourfold in 16·1% (five patients). IH-AAE is characterized by an important delay in diagnosis, a frequent involvement of the upper airway and a benign course during attacks. As in CU, a trial of up to fourfold dose of H1-anti-histamines may be necessary to control symptoms.

摘要

特发性组胺能获得性血管性水肿(IH - AAE)是反复出现无风团性血管性水肿的常见原因。它是一种肥大细胞介导的疾病,被认为与慢性荨麻疹(CU)属于同一临床实体。本研究的目的是描述IH - AAE患者的临床和流行病学特征。2014年至2015年期间,我们国家血管性水肿和/或荨麻疹参考中心共诊治了534例患者。其中,我们确定了31例患有特发性组胺能获得性无风团血管性水肿(IH - AAE)的患者。31例患者(15名男性和16名女性),平均年龄50岁,符合IH - AAE的标准。诊断的平均延迟时间为6.3年。12例患者(38.7%)有过敏史,其中9例患有过敏性鼻炎。发作的平均持续时间为28.1小时。54.8%的病例(17例患者)血管性水肿发作位于上呼吸道。29%的患者发现有舌部受累。男性比女性更易出现上气道受累。未报告有插管或入住重症监护病房的情况。51.6%的患者(16例)控制症状所需的抗组胺药剂量是推荐剂量的1倍,32%(10例)是2倍,16.1%(5例)是3至4倍。IH - AAE的特点是诊断延迟时间长、上气道频繁受累且发作期病程良性。与慢性荨麻疹一样,可能需要试用高达4倍剂量的H1抗组胺药来控制症状。

相似文献

2
[Histaminergic angioedema and chronic urticaria].[组胺能性血管性水肿与慢性荨麻疹]
Presse Med. 2015 Jan;44(1):37-42. doi: 10.1016/j.lpm.2014.11.001. Epub 2014 Dec 18.
4
Angioedema without wheals: a clinical update.无风团性血管性水肿:临床更新。
Balkan Med J. 2021 Mar;38(2):73-81. doi: 10.5152/balkanmedj.2021.20060.
8
Urticaria and angioedema.荨麻疹和血管性水肿。
Med Clin North Am. 1992 Jul;76(4):805-40. doi: 10.1016/s0025-7125(16)30327-3.
9
[Angioedema and urticaria].[血管性水肿和荨麻疹]
Ann Dermatol Venereol. 2014 Nov;141 Suppl 3:S586-95. doi: 10.1016/S0151-9638(14)70162-0.

引用本文的文献

5
Idiopathic Angioedema: Current Challenges.特发性血管性水肿:当前面临的挑战
J Asthma Allergy. 2020 Apr 17;13:137-144. doi: 10.2147/JAA.S205709. eCollection 2020.
9
Efficacy of Treatment of Non-hereditary Angioedema.非遗传性血管性水肿的治疗效果。
Clin Rev Allergy Immunol. 2018 Jun;54(3):412-431. doi: 10.1007/s12016-016-8585-0.

本文引用的文献

1
Gender-related differences in chronic urticaria.
G Ital Dermatol Venereol. 2016 Oct;151(5):544-52. Epub 2015 Jun 19.
6
Angioedema.血管性水肿。
Immunol Allergy Clin North Am. 2014 Feb;34(1):23-31. doi: 10.1016/j.iac.2013.09.004. Epub 2013 Oct 20.
10
Angioedema.血管性水肿
J Am Acad Dermatol. 2005 Sep;53(3):373-88; quiz 389-92. doi: 10.1016/j.jaad.2004.09.032.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验